Copyright
©2012 Baishideng Publishing Group Co.
World J Diabetes. Jun 15, 2012; 3(6): 118-122
Published online Jun 15, 2012. doi: 10.4239/wjd.v3.i6.118
Published online Jun 15, 2012. doi: 10.4239/wjd.v3.i6.118
Table 1 Baseline characteristics
| Add-on group (n = 35) | Switching group (n = 19) | Control group (n = 24) | P value | |
| Age (yr) | 64.66 ± 10.63 | 55.84 ± 12.96 | 63.04 ± 8.85 | 0.171 |
| Gender | ||||
| Male | 28 | 15 | 18 | 0.897 |
| Female | 7 | 4 | 6 | |
| Disease duration (yr) | 11.98 ± 9.66 | 10.00 ± 11.22 | 8.31 ± 8.25 | 0.797 |
| Body mass index (kg/m2) | 24.28 ± 3.49 | 23.94 ± 3.69 | 25.20 ± 3.27 | 0.536 |
| Using sulfonylureas | 16 | 12 | 13 | 0.463 |
- Citation: Matsuhashi T, Sano M, Fukuda K, Kohsaka S, Suzuki Y. Sitagliptin counteracts seasonal fluctuation of glycemic control. World J Diabetes 2012; 3(6): 118-122
- URL: https://www.wjgnet.com/1948-9358/full/v3/i6/118.htm
- DOI: https://dx.doi.org/10.4239/wjd.v3.i6.118